Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Kumar, Reddi K.a | Basu, Sayantanib; c | Lemke, Horst-Dieterd | Jankowski, Joachime; f | Kratz, Karlb | Lendlein, Andreasb; c | Tetali, Sarada D.a; *
Affiliations: [a] Department of Plant Sciences, School of Life Sciences, University of Hyderabad, Hyderabad, India | [b] Institute of Biomaterial Science and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Geesthacht, Teltow, Germany | [c] Institute of Chemistry, University Potsdam, Potsdam, Germany | [d] eXcorLab GmbH, Industrie Center Obernburg, Obernburg, Germany | [e] Institute for Molecular Cardiovascular Research (IMCAR), RTWTH Aachen University, University Hospital, Aachen, Germany | [f] School of Cardiovascular Diseases (CARIM), University of Maastricht, Maastricht, The Netherlands
Correspondence: [*] Corresponding author: Dr. Sarada D. Tetali, Associate Professor, Department of Plant Sciences, School of Life Sciences,University of Hyderabad, Hyderabad 500 046, India. Tel.: +91 40 23134512; Fax: +91 40 23010120; E-mail: stetali@uohyd.ac.in; saradakanakagiri@gmail.com.
Abstract: Current haemodialysis techniques are not capable to remove efficiently low molecular weight hydrophobic uremic toxins from the blood of patients suffering from chronic renal failure. With respect to the hydrophobic characteristics and the high level of protein binding of these uremic toxins, hydrophobic adsorber materials might be an alternative to remove these substances from the plasma of the chronic kidney disease (CKD) patients. Here nanoporous microparticles prepared from poly(ether imide) (PEI) with an average diameter of 90 ± 30 μm and a porosity around 88 ± 2% prepared by a spraying/coagulation process are considered as candidate adsorber materials. A prerequisite for the clinical application of such particles is their biocompatibility, which can be examined i.e. indirectly in cell culture experiments with the particles’ extracts. In this work we studied the effects of aqueous extracts of PEI microparticles on the viability of THP-1 cells, a human leukemia monocytic cell line, as well as their macrophage differentiation, reactive oxygen species (ROS) generation and inflammation. A high cell viability of around 99 ± 18% and 99 ± 5% was observed when THP-1 cells were cultured in the presence of aqueous extracts of the PEI microparticles in medium A and medium B respectively. The obtained microscopic data suggested that PEI particle extracts have no significant effect on cell death, oxidative stress or differentiation to macrophages. It was further found that the investigated proinflammatory markers in THP-1 cells were not up-regulated. These results are promising with regard to the biocompatibility of PEI microparticles and in a next step the hemocompatibility of the microparticles will be examined.
Keywords: Chronic kidney disease (CKD), cytotoxicity, human monocytic (THP-1) cells, poly(ether imide) microparticles, reactive oxygen species (ROS)
DOI: 10.3233/CH-152027
Journal: Clinical Hemorheology and Microcirculation, vol. 61, no. 4, pp. 667-680, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl